Free Design Audit Available - Click Here for Details

Neurovalens wins FDA nod for anxiety-treating neuromod device, raises $2.65M

Neurovalens announced today that it received FDA clearance for its Modius Stress device for treating anxiety and raised $2.65 million.

Belfast, Northern Ireland–based Neurovalens designed Modius Stress to deliver non-invasive electrical stimulation. It stimulates key areas of the brain and nervous system without the need for surgically implanted electrodes.

Modius Stress treats anxiety with a small and safe electrical pulse delivered to the head for 30 minutes before bed. During this time, users can perform other activities, like watching TV or reading. People with generalized anxiety disorder (GAD) across the U.S. with a prescription can utilize this device now.

Sign up for Blog Updates